Fundraising FoxBiotech Startups
11,136 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
Sulfagenix develops SG1002, an oral hydrogen sulfide prodrug designed to treat oxidative stress-related diseases including cardiovascular disorders, cancer, and other chronic conditions. The company targets patients with conditions ranging from heart failure to cancer, diabetes, and neurodegeneration.
0 investors
SummaCor develops medical device technologies, including the LCAPP, for cardiac care led by a team of cardiologists and engineers. The company focuses on heart-related medical technology with clinical and advisory input from cardiology and heart failure specialists.
0 investors
0 investors
0 investors
Summit Therapeutics is a biopharmaceutical oncology company developing and commercializing cancer therapies, with a lead candidate, ivonescimab (SMT112/AK112), a bispecific antibody targeting PD-1 and VEGF currently in Phase 3 trials for non-small cell lung cancer. It licenses ivonescimab from Akeso for territories including the US, Canada, Europe, Japan, Latin America, the Middle East, and Africa.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Superior Genomics is an early-stage health technology company developing diagnostic blood tests that distinguish depressive symptoms as either Bipolar Disorder or Major Depressive Disorder, based on gene expression bioprofiles found in blood. It aims to provide objective diagnostic tools for mental health disorders in clinical settings.
0 investors
Surface Ophthalmics is a biopharmaceutical company developing topical eyedrop treatments for dry eye syndrome and post-surgical ocular conditions. The company has evaluated multiple formulations through Phase II clinical trials and is pursuing three proprietary candidates for commercialization.
0 investors
Surrozen is a biotechnology company developing antibody-based therapeutics that activate the Wnt signaling pathway to promote tissue repair, with initial focus on ophthalmology indications including diabetic macular edema, wet age-related macular degeneration, and corneal endothelial disease.
0 investors
0 investors
Sus Clinicals provides preclinical testing services using its Oncopig cancer model, a large-animal platform that induces tumors and other diseases on demand to generate predictive data for medical devices, drugs, and diagnostics. It serves healthcare and therapeutics developers seeking to accelerate drug and device development toward clinical trials.
0 investors
0 investors
Vaxcyte is a biotech company developing vaccines to treat or prevent serious infectious diseases. The company is led by experienced vaccinologists and pharma industry veterans.
0 investors
0 investors
0 investors
0 investors
0 investors